DAN Stock Analysis: Dana | NYSE
Auto Parts | NYSE, USA | Market Cap: 2.736m USD | 12M Return: 61.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 59.8M
EPS Trend: -29.6%
Qual. Beats: 0
Rev. Trend: -89.8%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Dana Incorporated (NYSE: DAN) is a U.S.-based supplier of power-conveyance and energy-management solutions for on-highway light and commercial vehicles, operating across North America, Europe, South America, and Asia Pacific. The company reports through two segments: Light Vehicle and Commercial Vehicle.
Its product portfolio spans axles, driveshafts, transmissions (including internal combustion, hybrid, and electric variants), e-axle and e-transmission systems, inverters, electric motors, controllers, sealing components, and thermal-management technologies such as battery and hydrogen fuel cell cooling. Dana also offers electrodynamic components, battery-management systems, fuel cell plates, and digital solutions covering active and passive controls and analytics.
Founded in 1904 and headquartered in Maumee, Ohio, Dana has been listed since 2008 and was renamed from Dana Holding Corporation to Dana Incorporated in August 2016. The Automotive Parts & Equipment industry is currently transitioning toward electrified powertrains, and Danas product mix, which includes both traditional ICE components and EV-specific systems such as e-axles and electric motors, reflects exposure to both legacy and electrified vehicle platforms.
- Commercial vehicle volumes swing with North American Class 8 truck cycles
- EV component bookings accelerate as OEMs shift to electrified platforms
- Light Vehicle revenue tracks North American OEM production schedules
| Net Income: -162.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.38 > 1.0 |
| NWC/Revenue: 15.61% < 20% (prev 13.06%; Δ 2.55% < -1%) |
| CFO/TA 0.06 > 3% & CFO 354.0m > Net Income -162.0m |
| Net Debt (1.33b) to EBITDA (425.0m): 3.12 < 3 |
| Current Ratio: 1.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (109.9m) vs 12m ago -25.24% < -2% |
| Gross Margin: 8.03% > 18% (prev 7.82%; Δ 0.21% > 0.5%) |
| Asset Turnover: 108.1% > 50% (prev 118.1%; Δ -9.99% > 0%) |
| Interest Coverage Ratio: 0.52 > 6 (EBIT TTM 85.0m / Interest Expense TTM 164.0m) |
| A: 0.19 (Total Current Assets 3.24b - Total Current Liabilities 2.07b) / Total Assets 6.08b |
| B: 0.22 (Retained Earnings 1.31b / Total Assets 6.08b) |
| C: 0.01 (EBIT TTM 85.0m / Avg Total Assets 6.94b) |
| D: 0.48 (Book Value of Equity 1.96b / Total Liabilities 4.06b) |
| Altman-Z'' = 2.55 = A |
| DSRI: 1.14 (Receivables 1.54b/1.66b, Revenue 7.50b/9.21b) |
| GMI: 0.97 (GM 7.82% / 8.03%) |
| AQI: 0.80 (AQ_t 0.13 / AQ_t-1 0.16) |
| SGI: 0.81 (Revenue 7.50b / 9.21b) |
| TATA: -0.08 (NI -162.0m - CFO 354.0m) / TA 6.08b) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of July 11, 2026, the stock is trading at USD 27.33 with a total of 1,337,344 shares traded. Over the past week, the price has changed by +9.71%, over one month by -22.95%, over three months by -24.78% and over the past year by +61.20%.
Current recommended Stop Loss: 25.50 (which is 6.7% or 1.3 ATR below the current price).
Dana has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy DAN.
- StrongBuy: 2
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 40 | 46.4% |
P/E Forward = 10.8814
P/S = 0.3606
P/B = 1.3707
P/EG = 6.8516
Revenue TTM = 7.50b USD
EBIT TTM = 85.0m USD
EBITDA TTM = 425.0m USD
Long Term Debt = 1.24b USD (from longTermDebt, last quarter)
Short Term Debt = 62.0m USD (from shortTermDebt, last quarter)
Debt = 1.81b USD (from shortLongTermDebtTotal, last quarter) + Leases 275.0m
Net Debt = 1.33b USD (calculated: Debt 1.81b - CCE 483.0m)
Enterprise Value = 4.06b USD (2.74b + Debt 1.81b - CCE 483.0m)
Interest Coverage Ratio = 0.52 (Ebit TTM 85.0m / Interest Expense TTM 164.0m)
EV/FCF = 26.55x (Enterprise Value 4.06b / FCF TTM 153.0m)
FCF Yield = 3.77% (FCF TTM 153.0m / Enterprise Value 4.06b)
FCF Margin = 2.04% (FCF TTM 153.0m / Revenue TTM 7.50b)
Net Margin = -2.16% (Net Income TTM -162.0m / Revenue TTM 7.50b)
Gross Margin = 8.03% ((Revenue TTM 7.50b - Cost of Revenue TTM 6.90b) / Revenue TTM)
Gross Margin QoQ = 8.62% (prev none%)
Tobins Q-Ratio = 0.67 (Enterprise Value 4.06b / Total Assets 6.08b)
Interest Expense / Debt = 9.06% (Interest Expense 164.0m / Debt 1.81b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 67.2m (EBIT 85.0m * (1 - 21.00%))
Current Ratio = 1.57 (Total Current Assets 3.24b / Total Current Liabilities 2.07b)
Debt / Equity = 0.93 (Debt 1.81b / totalStockholderEquity, last quarter 1.96b)
Debt / EBITDA = 3.12 (Net Debt 1.33b / EBITDA 425.0m)
Debt / FCF = 8.67 (Net Debt 1.33b / FCF TTM 153.0m)
Total Stockholder Equity = 1.28b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.33% (Net Income -162.0m / Total Assets 6.08b)
RoE = -12.67% (Net Income TTM -162.0m / Total Stockholder Equity 1.28b)
RoCE = 3.38% (EBIT 85.0m / Capital Employed (Equity 1.28b + L.T.Debt 1.24b))
RoIC = 1.82% (NOPAT 67.2m / Invested Capital 3.70b)
WACC = 10.15% (E(2.74b)/V(4.55b) * Re(12.13%) + D(1.81b)/V(4.55b) * Rd(9.06%) * (1-Tc(0.21)))
Discount Rate = 12.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -34.10 | Cagr: -11.45%
[DCF] Terminal Value 67.97% ; FCFF base≈158.6m ; Y1≈148.0m ; Y5≈135.5m
[DCF] Fair Price = 2.98 (EV 1.65b - Net Debt 1.33b = Equity 320.5m / Shares 107.6m; r=10.15% [WACC]; 5y FCF grow -8.38% → 2.50% )
EPS Correlation: -29.65 | EPS CAGR: -5.51% | SUE: 0.47 | # QB: 0
Revenue Correlation: -89.82 | Revenue CAGR: -15.71% | SUE: 0.11 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.71 | Chg30d=+6.52% | Revisions=+0% | Analysts=7
EPS next Quarter (2026-09-30): EPS=0.85 | Chg30d=+5.43% | Revisions=-17% | Analysts=7
EPS current Year (2026-12-31): EPS=2.50 | Chg30d=+0.99% | Revisions=-12% | GrowthEPS=+485.6% | GrowthRev=+2.2%
EPS next Year (2027-12-31): EPS=3.37 | Chg30d=-7.52% | Revisions=+17% | GrowthEPS=+35.1% | GrowthRev=+48.5%
[Analyst] Revisions Ratio: -6% (up=6, down=7)